Top

Published in:

01-10-2020 | Fibromyalgia | Review

The effectiveness and safety of electrotherapy in the management of fibromyalgia

Author: Ilke Coskun Benlidayi

Published in: Rheumatology International | Issue 10/2020

Abstract

Treating fibromyalgia is a challenging task for physicians. With its multifaceted features, fibromyalgia requires a comprehensive management strategy focusing on both the pharmacological and non-pharmacological treatment options. During the last decades, there has been growing evidence regarding the role of electrotherapy in fibromyalgia treatment. In this regard, the present article aimed to review the recent literature on the effectiveness and safety of the electrotherapy in the treatment of fibromyalgia. A literature search was conducted through PubMed/MEDLINE and Scopus databases. Transcutaneous electrical nerve stimulation (TENS), non-invasive brain stimulation (transcranial direct current/magnetic stimulation), and light amplification by stimulated emission of radiation (LASER) emerged as the most commonly examined electrotherapy techniques in fibromyalgia. Currently, there is growing data regarding the effectiveness of electrotherapy in the management of fibromyalgia-related pain. Besides, non-invasive electrotherapy techniques are related to no/minor side effects. Further studies are warranted to identify the optimal treatment protocols for each electrotherapy modality.

Bussel B (2015) History of electrical stimulation in rehabilitation medicine. Ann Phys Rehabil Med 58:198–200. https://doi.org/10.1016/j.rehab.2015.04.008CrossRefPubMed

Staud R, Smitherman ML (2002) Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep 6:259–266. https://doi.org/10.1007/s11916-002-0046-1CrossRefPubMed

Staud R, Domingo M (2001) Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med 2:208–215. https://doi.org/10.1046/j.1526-4637.2001.01030.xCrossRefPubMed

Mutlu B, Paker N, Bugdayci D, Tekdos D, Kesiktas N (2013) Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatol Int 33:649–655. https://doi.org/10.1007/s00296-012-2390-8CrossRefPubMed

Dailey DL, Rakel BA, Vance CG, Liebano RE, Amrit AS, Bush HM, Lee KS, Lee JE, Sluka KA (2013) Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain 154:2554–2562. https://doi.org/10.1016/j.pain.2013.07.043CrossRefPubMedPubMedCentral

Fagerlund AJ, Hansen OA, Aslaksen PM (2015) Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain 156:62–71. https://doi.org/10.1016/j.pain.0000000000000006CrossRefPubMed

Castillo-Saavedra L, Gebodh N, Bikson M, Diaz-Cruz C, Brandao R, Coutinho L, Truong D, Datta A, Shani-Hershkovich R, Weiss M, Laufer I, Reches A, Peremen Z, Geva A, Parra LC, Fregni F (2016) Clinically effective treatment of fibromyalgia pain with high-definition transcranial direct current stimulation: phase ii open-label dose optimization. J Pain 17:14–26. https://doi.org/10.1016/j.jpain.2015.09.009CrossRefPubMed

Tzabazis A, Aparici CM, Rowbotham MC, Schneider MB, Etkin A, Yeomans DC (2013) Shaped magnetic field pulses by multi-coil repetitive transcranial magnetic stimulation (rTMS) differentially modulate anterior cingulate cortex responses and pain in volunteers and fibromyalgia patients. Mol Pain 9:33. https://doi.org/10.1186/1744-8069-9-33CrossRefPubMedPubMedCentral

Vayvay ES, Tok D, Turgut E, Tunay VB (2016) The effect of Laser and taping on pain, functional status and quality of life in patients with fibromyalgia syndrome: a placebo-randomized controlled clinical trial. J Back Musculoskelet Rehabil 29:77–83CrossRef

10.

Boyer L, Dousset A, Roussel P, Dossetto N, Cammilleri S, Piano V, Khalfa S, Mundler O, Donnet A, Guedj E (2014) rTMS in fibromyalgia: a randomized trial evaluating QoL and its brain metabolic substrate. Neurology 82:1231–1238. https://doi.org/10.1212/WNL.0000000000000280CrossRefPubMed

11.

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3CrossRefPubMed

12.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76:318–328. https://doi.org/10.1136/annrheumdis-2016-209724CrossRefPubMed

13.

Taylor SJ, Steer M, Ashe SC, Furness PJ, Haywood-Small S, Lawson K (2019) Patients’ perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia. Scand J Pain 19:167–181. https://doi.org/10.1515/sjpain-2018-0116CrossRefPubMed

14.

Johnson MI, Claydon LS, Herbison GP, Jones G, Paley CA (2017) Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev 10:CD012172. https://doi.org/10.1002/14651858 (CD012172.pub2)CrossRefPubMed

15.

Martimbianco ALC, Porfírio GJ, Pacheco RL, Torloni MR, Riera R (2019) Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database Syst Rev 12:CD011927. https://doi.org/10.1002/14651858.CD011927 (pub2)CrossRefPubMed

16.

Johnson M (2007) Transcutaneous electrical nerve stimulation: mechanisms, clinical application and evidence. Rev Pain 1:7–11. https://doi.org/10.1177/204946370700100103CrossRefPubMedPubMedCentral

17.

Sherry JE, Oehrlein KM, Hegge KS, Morgan BJ (2001) Effect of burst-mode transcutaneous electrical nerve stimulation on peripheral vascular resistance. Phys Ther 81:1183–1191CrossRef

18.

Lauretti GR, Chubaci EF, Mattos AL (2013) Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatol Int 33:2117–2122. https://doi.org/10.1007/s00296-013-2699-yCrossRefPubMed

19.

Carbonario F, Matsutani LA, Yuan SL, Marques AP (2013) Effectiveness of high-frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. Eur J Phys Rehabil Med 49:197–204PubMed

20.

Dailey DL, Vance CGT, Rakel BA, Zimmerman MB, Embree J, Merriwether EN, Geasland KM, Chimenti R, Williams JM, Golchha M, Crofford LJ, Sluka KA (2020) Transcutaneous electrical nerve stimulation reduces movement-evoked pain and fatigue: a randomized, controlled trial. Arthritis Rheumatol 72:824–836. https://doi.org/10.1002/art.41170CrossRefPubMedPubMedCentral

21.

Vance CG, Chimenti RL, Dailey DL, Hadlandsmyth K, Zimmerman MB, Geasland KM, Williams JM, Merriwether EN, Alemo Munters L, Rakel BA, Crofford LJ, Sluka KA (2018) Development of a method to maximize the transcutaneous electrical nerve stimulation intensity in women with fibromyalgia. J Pain Res 11:2269–2278. https://doi.org/10.2147/JPR.S168297CrossRefPubMedPubMedCentral

22.

Scaturro D, Guggino G, Tumminelli LG, Ciccia F, Letizia Mauro G (2019) An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia. Clin Exp Rheumatol 37:670–675PubMed

23.

Watt J (2013) Transcutaneous electrical nerve stimulation. Encycl Pain https://doi.org/10.1007/978-3-642-28753-4_4555CrossRef

24.

Yuksel M, Ayas S, Cabioglu MT, Yilmaz D, Cabioglu C (2019) Quantitative data for transcutaneous electrical nerve stimulation and acupuncture effectiveness in treatment of fibromyalgia syndrome. Evid Based Complement Alternat Med 2019:9684649. https://doi.org/10.1155/2019/9684649CrossRefPubMedPubMedCentral

25.

Eken A, Kara M, Baskak B, Baltaci A, Gokcay D (2018) Differential efficiency of transcutaneous electrical nerve stimulation in dominant versus nondominant hands in fibromyalgia: placebo-controlled functional near-infrared spectroscopy study. Neurophotonics 5:011005. https://doi.org/10.1117/1.NPh.5.1.011005CrossRefPubMed

26.

Cummiford CM, Nascimento TD, Foerster BR, Clauw DJ, Zubieta JK, Harris RE, DaSilva AF (2016) Changes in resting state functional connectivity after repetitive transcranial direct current stimulation applied to motor cortex in fibromyalgia patients. Arthritis Res Ther 18:40. https://doi.org/10.1186/s13075-016-0934-0CrossRefPubMedPubMedCentral

27.

Mendonca ME, Simis M, Grecco LC, Battistella LR, Baptista AF, Fregni F (2016) Transcranial direct current stimulation combined with aerobic exercise to optimize analgesic responses in fibromyalgia: a randomized placebo-controlled clinical trial. Front Hum Neurosci 10:68. https://doi.org/10.3389/fnhum.2016.00068CrossRefPubMedPubMedCentral

28.

Guinot M, Maindet C, Hodaj H, Hodaj E, Bachasson D, Baillieul S, Cracowski JL, Launois S (2019) Effects of repetitive transcranial magnetic stimulation and multicomponent therapy in patients with fibromyalgia: a randomized controlled trial. Arthr Care Res (Hoboken) https://doi.org/10.1002/acr.24118 (Epub ahead of print)CrossRef

29.

Taylor AG, Anderson JG, Riedel SL, Lewis JE, Kinser PA, Bourguignon C (2013) Cranial electrical stimulation improves symptoms and functional status in individuals with fibromyalgia. Pain Manag Nurs 14:327–335. https://doi.org/10.1016/j.pmn.2011.07.002CrossRefPubMed

30.

Foerster BR, Nascimento TD, DeBoer M, Bender MA, Rice IC, Truong DQ, Bikson M, Clauw DJ, Zubieta JK, Harris RE, DaSilva AF (2015) Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia. Arthritis Rheumatol 67:576–581CrossRef

31.

Brighina F, Curatolo M, Cosentino G, De Tommaso M, Battaglia G, Sarzi-Puttini PC, Guggino G, Fierro B (2019) Brain modulation by electric currents in fibromyalgia: a structured review on non-invasive approach with transcranial electrical stimulation. Front Hum Neurosci 13:40. https://doi.org/10.3389/fnhum.2019.00040CrossRefPubMedPubMedCentral

32.

Coskun Benlidayi I (2018) Fibromyalgia as a challenge for patients and physicians. Rheumatol Int 38:2345. https://doi.org/10.1007/s00296-018-4138-6CrossRefPubMed

33.

Brietzke AP, Zortea M, Carvalho F, Sanches PRS, Silva DPJ, Torres ILDS, Fregni F, Caumo W (2019) Large treatment effect with extended home-based transcranial direct current stimulation over dorsolateral prefrontal cortex in fibromyalgia: a proof of concept sham-randomized clinical study. J Pain https://doi.org/10.1016/j.jpain.2019.06.013 (pii:S1526-5900(19)30770-9)CrossRefPubMed

34.

Santos VSDSD, Zortea M, Alves RL, Naziazeno CCDS, Saldanha JS, Carvalho SDCR, Leite AJDC, Torres ILDS, Souza A, Calvetti PÜ, Fregni F, Caumo W (2018) Cognitive effects of transcranial direct current stimulation combined with working memory training in fibromyalgia: a randomized clinical trial. Sci Rep 8:12477. https://doi.org/10.1038/s41598-018-30127-zCrossRefPubMedPubMedCentral

35.

Silva AF, Zortea M, Carvalho S, Leite J, Torres IL, Fregni F, Caumo W (2017) Anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex modulates attention and pain in fibromyalgia: randomized clinical trial. Sci Rep 7:135. https://doi.org/10.1038/s41598-017-00185-wCrossRefPubMedPubMedCentral

36.

Khedr EM, Omran EAH, Ismail NM, El-Hammady DH, Goma SH, Kotb H, Galal H, Osman AM, Farghaly HSM, Karim AA, Ahmed GA (2017) Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: a double blinded, randomized clinical trial. Brain Stimul 10:893–901. https://doi.org/10.1016/j.brs.2017.06.006CrossRefPubMed

37.

Villamar MF, Wivatvongvana P, Patumanond J, Bikson M, Truong DQ, Datta A, Fregni F (2013) Focal modulation of the primary motor cortex in fibromyalgia using 4×1-ring high-definition transcranial direct current stimulation (HD-tDCS): immediate and delayed analgesic effects of cathodal and anodal stimulation. J Pain 14:371–383. https://doi.org/10.1016/j.jpain.2012.12.007CrossRefPubMed

38.

De Ridder D, Vanneste S (2017) Occipital nerve field transcranial direct current stimulation normalizes imbalance between pain detecting and pain inhibitory pathways in fibromyalgia. Neurotherapeutics 14:484–501. https://doi.org/10.1007/s13311-016-0493-8CrossRefPubMed

39.

Yoo HB, Ost J, Joos W, Van Havenbergh T, De Ridder D, Vanneste S (2018) Adding prefrontal transcranial direct current stimulation before occipital nerve stimulation in fibromyalgia. Clin J Pain 34:421–427. https://doi.org/10.1097/AJP.0000000000000552CrossRefPubMed

40.

To WT, James E, Ost J, Hart J Jr, De Ridder D, Vanneste S (2017) Differential effects of bifrontal and occipital nerve stimulation on pain and fatigue using transcranial direct current stimulation in fibromyalgia patients. J Neural Transm (Vienna) 124:799–808. https://doi.org/10.1007/s00702-017-1714-yCrossRef

41.

Carvalho F, Brietzke AP, Gasparin A, Dos Santos FP, Vercelino R, Ballester RF, Sanches PRS, da Silva DP, Torres ILS, Fregni F, Caumo W (2018) Home-based transcranial direct current stimulation device development: an updated protocol used at home in healthy subjects and fibromyalgia patients. J Vis Exp https://doi.org/10.3791/57614(137)CrossRefPubMedPubMedCentral

42.

Berlim MT, Van den Eynde F, Jeff Daskalakis Z (2013) Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 38:543–551. https://doi.org/10.1038/npp.2012.237CrossRefPubMed

43.

Altas EU, Askin A, Beşiroğlu L, Tosun A (2019) Is high-frequency repetitive transcranial magnetic stimulation of the left primary motor cortex superior to the stimulation of the left dorsolateral prefrontal cortex in fibromyalgia syndrome? Somatosens Mot Res 36:56–62. https://doi.org/10.1080/08990220.2019.1587400CrossRefPubMed

44.

Tekin A, Ozdil E, Güleken MD, Iliser R, Bakim B, Oncu J, Cevik M, Kuran B (2014) Efficacy of high frequency [10 Hz] repetitive transcranial magnetic stimulation of the primary motor cortex in patients with fibromyalgia syndrome: a randomized double blind, sham-controlled trial. J Musculoskelet Pain 22:20–26. https://doi.org/10.3109/10582452.2014.883042CrossRef

45.

Abd Elghany SE, Al Ashkar DS, El-Barbary AM, El Khouly RM, Aboelhawa MA, Nada DW, Darwish NF, Hussein MS, Rageh ES, Abo-Zaid MH, Eldesoky IF, Afifi S (2019) Regenerative injection therapy and repetitive transcranial magnetic stimulation in primary fibromyalgia treatment: a comparative study. J Back Musculoskelet Rehabil 32:55–62. https://doi.org/10.3233/BMR-181127CrossRefPubMed

46.

Fitzgibbon BM, Hoy KE, Knox LA, Guymer EK, Littlejohn G, Elliot D, Wambeek LE, McQueen S, Elford KA, Lee SJ, Enticott PG, Fitzgerald PB (2018) Evidence for the improvement of fatigue in fibromyalgia: a 4-week left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation randomized-controlled trial. Eur J Pain 22:1255–1267. https://doi.org/10.1002/ejp.1213CrossRefPubMed

47.

Avery DH, Zarkowski P, Krashin D, Rho WK, Wajdik C, Joesch JM, Haynor DR, Buchwald D, Roy-Byrne P (2015) Transcranial magnetic stimulation in the treatment of chronic widespread pain: a randomized controlled study. J ECT 31:57–66. https://doi.org/10.1097/YCT.0000000000000125CrossRefPubMedPubMedCentral

48.

Baudic S, Attal N, Mhalla A, Ciampi de Andrade D, Perrot S, Bouhassira D (2013) Unilateral repetitive transcranial magnetic stimulation of the motor cortex does not affect cognition in patients with fibromyalgia. J Psychiatr Res 47:72–77. https://doi.org/10.1016/j.jpsychires.2012.09.003CrossRefPubMed

49.

Maestú C, Blanco M, Nevado A, Romero J, Rodríguez-Rubio P, Galindo J, Bautista Lorite J, de las Morenas F, Fernández-Argüelles P (2013) Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: a double-blinded, randomized placebo-controlled clinical trial. Pain Res Manag 18:e101–e106CrossRef

50.

Yagci I, Agırman M, Ozturk D, Eren B (2014) Is the transcranial magnetic stimulation an adjunctive treatment in fibromyalgia patients? Turk J Phys Med Rehab 60:206–211. https://doi.org/10.5152/tftrd.2014.37074CrossRef

51.

Germano Maciel D, Trajano da Silva M, Rodrigues JA, Viana Neto JB, de França IM, Melo ABM, Barros da Silva TYP, de Brito Vieira WH (2018) Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial. Lasers Med Sci 33:1949–1959. https://doi.org/10.1007/s10103-018-2561-2CrossRefPubMed

52.

Ruaro JA, Fréz AR, Ruaro MB, Nicolau RA (2014) Low-level laser therapy to treat fibromyalgia. Lasers Med Sci 29:1815–1819. https://doi.org/10.1007/s10103-014-1566-8CrossRefPubMed

53.

Molina-Torres G, Rodríguez-Archilla A, Matarán-Peñarrocha G, Albornoz-Cabello M, Aguilar-Ferrándiz ME, Castro-Sánchez AM (2016) Laser therapy and occlusal stabilization splint for temporomandibular disorders in patients with fibromyalgia syndrome: a randomized, clinical trial. Altern Ther Health Med 22:23–31PubMed

54.

Panton L, Simonavice E, Williams K, Mojock C, Kim JS, Kingsley JD, McMillan V, Mathis R (2013) Effects of class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J Altern Complement Med 19:445–452. https://doi.org/10.1089/acm.2011.0398CrossRefPubMed

55.

White PF, Zafereo J, Elvir-Lazo OL, Hernandez H (2018) Treatment of drug-resistant fibromyalgia symptoms using high-intensity laser therapy: a case-based review. Rheumatol Int 38:517–523. https://doi.org/10.1007/s00296-017-3856-5CrossRefPubMed

56.

Coskun Benlidayi I (2019) Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int 39:781–791. https://doi.org/10.1007/s00296-019-04251-6CrossRefPubMed

57.

Dos Santos RC, Souza Guedes KWHS, de Sousa Pinto JM, Oliveira MF (2020) Acute low-level laser therapy effects on peripheral muscle strength and resistance in patients with fibromyalgia. Lasers Med Sci 35:505–510. https://doi.org/10.1007/s10103-019-02816-2CrossRefPubMed

58.

da Silva MM, Albertini R, de Tarso Camillo, de Carvalho P, Leal-Junior ECP, Bussadori SK, Vieira SS, Bocalini DS, de Oliveira LVF, Grandinetti V, Silva JA Jr, Serra AJ (2018) Randomized, blinded, controlled trial on effectiveness of photobiomodulation therapy and exercise training in the fibromyalgia treatment. Lasers Med Sci 33:343–351. https://doi.org/10.1007/s10103-017-2388-2CrossRefPubMed

59.

de Souza RC, de Sousa ET, Scudine KG, Meira UM, de Oliveira E, Silva EM, Gomes AC, Limeira-Junior FA (2018) Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial. Med Oral Patol Oral Cir Bucal 23:e65–e71. https://doi.org/10.4317/medoral.21965CrossRefPubMed

60.

Plazier M, Ost J, Stassijns G, De Ridder D, Vanneste S (2015) C2 nerve field stimulation for the treatment of fibromyalgia: a prospective, double-blind, randomized, controlled cross-over study. Brain Stimul 8:751–757. https://doi.org/10.1016/j.brs.2015.03.002CrossRefPubMed

61.

Ahmed S, Plazier M, Ost J, Stassijns G, Deleye S, Ceyssens S, Dupont P, Stroobants S, Staelens S, De Ridder D, Vanneste S (2018) The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging study. BMC Neurol 18:191. https://doi.org/10.1186/s12883-018-1190-5CrossRefPubMedPubMedCentral

62.

Plazier M, Ost J, Snijders E, Gilbers M, Vancamp T, De Ridder D, Vanneste S (2015) Laser-evoked potentials in fibromyalgia: the influence of greater occipital nerve stimulation on cerebral pain processing. Neuromodulation 18:376–383. https://doi.org/10.1111/ner.12310CrossRefPubMed

63.

Multanen J, Häkkinen A, Heikkinen P, Kautiainen H, Mustalampi S, Ylinen J (2018) Pulsed electromagnetic field therapy in the treatment of pain and other symptoms in fibromyalgia: a randomized controlled study. Bioelectromagnetics 39:405–413. https://doi.org/10.1002/bem.22127CrossRefPubMed

64.

Oka H, Miki K, Kishita I, Kong DF, Uchida T (2020) A multicenter, prospective, randomized, placebo-controlled, double-blind study of a novel pain management device, AT-02, in patients with fibromyalgia. Pain Med 21:326–332. https://doi.org/10.1093/pm/pnz064CrossRefPubMed

65.

Salmon J (2019) High-frequency spinal cord stimulation at 10 kHz for widespread pain: a retrospective survey of outcomes from combined cervical and thoracic electrode placements. Postgrad Med 131:230–238. https://doi.org/10.1080/00325481.2019.1587564CrossRefPubMed

66.

Thieme K, Meller T, Evermann U, Malinowski R, Mathys MG, Graceley RH, Maixner W, Turk DC (2019) Efficacy of systolic extinction training in fibromyalgia patients with elevated blood pressure response to stress: a tailored randomized controlled trial. Arthr Care Res (Hoboken) 71:678–688. https://doi.org/10.1002/acr.23615CrossRef

67.

Díaz-Toral LG, Banderas-Dorantes TR, Rivas-Vilchis JF (2017) Impact of electroacupuncture treatment on quality of life and heart rate variability in fibromyalgia patients. J Evid Based Complement Altern Med 22:216–222. https://doi.org/10.1177/2156587215626615CrossRef

68.

Dias PA, Guimarães AB, Albuquerque Ade O, de Oliveira KL, Cavalcante ML, Guimarães SB (2016) Short-term complementary and alternative medicine on quality of life in women with fibromyalgia. J Integr Med 14:29–35. https://doi.org/10.1016/S2095-4964(16)60235-2CrossRefPubMed

Title: The effectiveness and safety of electrotherapy in the management of fibromyalgia
Author: Ilke Coskun Benlidayi
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Fibromyalgia
Fibromyalgia
Electrotherapy
Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation
Laser
Nerve Stimulation
Repetitive Transcranial Magnetic Stimulation
Physical Therapy
Published in: Rheumatology International / Issue 10/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04618-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The effectiveness and safety of electrotherapy in the management of fibromyalgia

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2020

Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database

Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19

Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review

Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms

Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes

The prevalence of fibromyalgia in axial spondyloarthritis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page